Overview
Adela is developing a blood test for the detection of cancer and other high-morbidity and high-mortality conditions. Adela’s genome-wide methylome enrichment platform efficiently captures genome-wide methylome information from small quantities of cell-free DNA and applies machine learning to detect and classify underlying disease.
Solution
Adela collaborated with GreyBox to develop the brand identity for the newly-launched company. Greybox created a logo, color palette, and typography for the brand, as well as a slide template.
